Canaccord Genuity Calls DexCom (DXCM) Quarter Solid, Says Momentum Building
Tweet Send to a Friend
Canaccord Genuity maintained a Buy rating on DexCom (NASDAQ: DXCM) with an adjusted price target of $19.00 (from $20).
This article: 130 words
-->
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This article: 130 words
-->
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
